Publicidad
Publicidad

Más contenido relacionado

Publicidad
Publicidad

BASICS OF PAN RETINAL, SECTOR AND FOCAL RETINAL LASER PHOTOCOAGULATION.pptx

  1. BASICS OF PAN RETINAL AND FOCAL RETINAL LASER PHOTOCOAGULATION PRESENTED BY DR. AVURU CHUKWUNALU JAMES 29/03/2023
  2. OUTLINE • INTRODUCTION • DEFINITION, PROPERTIES AND CLASSIFICATION OF LASER • USES OF LASERS • RETINAL PHOTOCOAGULATION • LASER DELIVERY SYSTEMS • PROCEDURE/ TECHNIQUES OF LASER ADMINISTRATION • LASERS IN GENERAL ANSD SPECIFIC CASES • RECENT ADVANCES IN RETINAL LASER PHOTOCOAGULATION • COMPLICATIONS OF LASER • CONCLUSION
  3. INTRODUCTION • LASER’ is an acronym for “Light Amplification by the Stimulated Emission of Radiation.” • Describes the emission process by which an intense beam of electromagnetic radiation is generated • When energy from laser is absorbed by the retinal pigment epithelium (RPE), it is converted into thermal energy. • Coagulation necrosis occurs with denaturation of cellular proteins as temperature rises above 65°C.
  4. PROPERTIES OF LASER • Monochromatic; one wavelength • Collimated; all photons run parallel & focused to a small point • Coherent; always in same phase • Highest possible speed
  5. THREE BASIC WAYS FOR PHOTONS AND ATOMS TO INTERACT: • Absorption • Spontaneous Emission • Stimulated Emission
  6. PHYSICS OF LASER • Some substances have property to absorb energy in one form & emit a new form of energy. • These substances are lasing in nature and obey Bohr’s theory. • On pumping these lasing substances, electrons are transfered from a lower orbit to higher orbit • Excited atoms in turn decay back to their original orbit of lower energy, emitting photons i.e packets of energy.
  7. LASER SYSTEM AND MEDIA • The lasering medium is contained in an optical cavity (resonator) with mirrors at both ends. • Reflect the light in the cavity and thereby circulate the photons through the lasing material multiple times to efficiently stimulate emission of radiation from excited atoms. • One of the mirrors is partially transmitting, thereby allowing a fraction of the laser beam to emerge.
  8. CLASSIFICATION OF LASING MEDIUM • The lasing medium can be Solid, Liquid or Gas • Lasers can be pumped by continuous discharge lamps and by pulsed flash lamps.
  9. RETINAL LASER THERAPEUTIC USES • Central serous chorioretinopathy • Retinal artery macroaneurym • Coats’ disease • Retinal capillary hemangioma • Choroidal hemangioma • Choroidal melanoma • YAG Laser hyaloidotomy • Optic disc pit • Most of the uses are now obsolete or 2nd line tx due to the advent of anti-VEGF • Diabetic retinopathy • Diabetic maculopathy • Retinal vein occlusion • Retinopathy of prematurity • Choroidal neovascularization (CNV) • Retinal lesions predisposing to detachment and retinal • Eales’ disease
  10. PHOTOCOAGULATION (PHC) BY LASERS • It is a photothermal reaction • Absorption of light by the target tissue results in a temperature rise of 20 to 30 deg C • Causes denaturization of proteins • This process is Pigment dependent • Typical lasers with photocoagulation effect • Argon, • Krypton dye, • Diode(810nm) • Frequency double Nd:Yag
  11. RETINA PHC LASER TYPES IN RETINA-ARGON BLUE- GREEN LASER • 70% blue (488 nm) and 30% green(514nm) • Absorbed selectively at retinal pigment epithelial layer (RPE), hemoglobin pigments, choriocapillaries, inner and outer nuclear layer of the retina. • It coagulates tissues between the choriocapillaris and inner nuclear layer. • Main adverse effects: high intraocular scattering, macular damage in photocoagulation near the fovea, and choroidal neovascularization (if Bruch's membrane is ruptured).
  12. RETINA PHC LASER TYPES CONTD • Frequency-doubled Nd-YAG Laser (532 nm): • Highly absorbed by hemoglobin, melanin in retinal pigment epithelium and trabecular meshwork. • can be used either continuously or in pulsed mode. • PASCAL (Pattern Scan Laser) is one such type of laser types • Krypton red (647 nm) • Well absorbed by melanin • can pass through hemoglobin • Suitable for treatment of subretinal neovascular membrane. • Has low intraocular scattering with good penetration through media opacity or edematous retina • Has ability to coagulate the choriocapillaries and the choroid.
  13. RETINA PHC LASER TYPES CONTD • Diode laser (805-810 nm): • It is well absorbed by melanin. • Has near to infrared spectrum (near invisible) which makes it more comfortable to use due to absence of flashes of light. • Has deep penetration through the retina and choroid • Laser of choice in treatment of Retinopathy of Prematurity (ROP) and some types of retina lesions. • Also used via trans-scleral route to treat the ciliary body
  14. TISSUE EFFECTS OF PHC • MOA : Increases the temp from 37 to 50 degrees • conformational changes, • Enzyme inactivation • Loss of structural integrity • Cell necrosis • Haemostasis and coagulation • Induces moderate sterile inflammation which creats Creates bio adhesion • Collagen shrinkage; usually beneficial • Membrane shrinkage; may produce harmful effect
  15. OCULAR PIGMENT ABSORPTION CHARACTERISTIC • Melanin; Entire visible range-300 to 1300 nm(absorbs green, yellow, red and infrared wavelengths). • Absorbs mainly wavelength between 400-700 nm. • Found mainly in the RPE (Retinal pigment epithelium) and choroid • Hemoglobin; range- 480 to 520nm • Absorption varies according to oxygen saturation. • It absorbs yellow, green, and blue wavelengths, but red light is absorbed poorly.
  16. OCULAR PIGMENT ABSORPTION CHARACTERISTIC CONTD • Xanthophyll- in the macular; Blue- 488nm(absorbs blue but minimally absorbs yellow or red wavelengths) • Located in the inner and outer plexiform retinal layers. • It protects the photoreceptors from short-wavelength light damage, but can be damaged by blue light. • When treating macular area, avoid blue lasers to prevent inadvertent damage to the macula. • Avoid blue lasers in Old people with lenticular opacities: lens absorbs, more scattering • Argon green, doubled frequencies Nd:Yag, 577dye are lasers of choice for macular photocoagulation
  17. SELECTION OF OPTICAL WAVELENGTH FOR COAGULATION • Wavelengths that are highly absorbed by macular pigments (such as 488 nm) are relatively contraindicated when treating in or near the macula. • Absorption of these wavelengths in macular leads to heating and destruction of the nerve fiber layer and vision loss. • Double ND:YAG or green Argon suited • Laser scattering and loss in patients with cataract or in vitreous opacities can be minimized using longer wavelengths: yellow (577 nm) or red (640–680 nm) • • Large quantity of hemoglobin- wavelengths between 520 and 580 nm are best suite
  18. LASER DELIVERY SYSTEMS • Slit lamp • Laser indirect ophthalmoscope (LIO) • Endo laser PHC
  19. LENSES USED FOR LASER DELIVERY
  20. LASER CONTACT LENSES
  21. PREREQUISITES FOR RETINAL PHC • Informed consent • Dilated pupil • Anaesthesia-Topical, peribulbar/retrobulbar • Fundus contact lens/3 or 4 mirror contact lens/ panfudoscopic lenses
  22. CHORIORETINAL BURN INTENSITY CLASSIFICATION • Light; barely visible retinal blanching • Mild; faint white retinal burn • Moderate; opaque dirty white retinal burn • Heavy; dense white retinal burn
  23. PAN RETINAL PHOTOCOAGULATION (PRP) AND SECTORAL PHC-INDICATIONS. 1,2 • Proliferative diabetic retinopathy (PDR): Very severe NPDR/ PDR( DRS, ETDRS) • Retinal vascular obstructions (CRVO); CVOS • Retinal vasculitis • Proliferative Sickle cell retinopathy • Ocular ischemic syndrome with proliferation • Retinopathy of prematurity; Treatment of threshold and high-risk prethreshold retinopathy of prematurity (ETROP)
  24. DEFINITION OF TERMS • POWER: No of photons emitted each second. Expressed in watts . • EXPOSURE TIME: The duration in seconds the photons are emitted from the laser in each burn. • SPOT SIZE: Diameter of the focussed laser beam expressed in microns. • Energy : No of photons emitted during an exposure of any duration. Expressed in Joules. ( J = W * Second )
  25. PROCEDURE-SAFETY/PRECAUTOARY MEASURE • Proper laser protection goggles for all staff assisting the procedure • The laser safety filter on the delivery system must be activated upon performing the procedure. • The procedure should be performed or supervised by an experienced ophthalmologist to avoid technical errors
  26. TECHNIQUE-POSITIONING • Slit lamp delivery system; patient in a sitting position. • Endolaser and transscleral delivery systems, the patient is supine. • With LIO; patient may be sitting or supine.
  27. PAN RETINA PHOTOCOAGULATION- LASER PARAMETERS • Spot size 200-500 microns • Duration 200 to 500 ms • Power 140-250mW (conventional): Up to 750mw depending on media clarity and delivery system. • Aim is to create a moderate intensity burn. • Each burn should be at least 1 burn width apart. • 900 burns are required for each half of the retina. • Total of 1800 to 2200 burns for complete treatment PRP.
  28. PROCEDURE/ TECHNIQUE (SLIT-LAMP DELIVERY) • General or local anaesthesia; GA, topical anaesthesia or give peribular (local block) • Place lens by asking patient to look up while lower lid is being retracted(non GA cases)
  29. PROCEDURE CONTD • Once lens is placed, focus to obtain clear view of retina. • Some providers prefer to divide treatment into two or more sessions while others elect to perform treatment in a single session.
  30. TECHNIQUE CONTD- LASER PRP • Start temporally just outside the vascular arcades and 3-disc diameters temporal to the macula, and extending to or just beyond the equator. • Nasal side of the fundus; begin about 1-disc diameter nasal to the optic disc and also extend to or just beyond the equator(do not go closer than 500 microns from the optic disc margin).
  31. PRCOCEDURE- PRP CONTD • However, specific regimens vary by practitioner. • Inferior half of retina is treated in first session and then superior half after 15 days. • If vitreous hemorrhage occurs, it would be difficult to apply laser to inferior half
  32. PROPOSED THEORIES OF EFFECT OF PRP • Injured RPE cells : thinning and anoxia of the outer retina. • More oxygen available to inner retina and vitreous. • Decreased stimulus for neovascularisation. • Also, PRP converts ischaemia to anoxia, no VEGF
  33. LASER INDIRECT OPHTHALMOSCOPE (LIO) DELIVERY-INDICATIONS • Media opacities like dense cataracts, vitreous hemorrhage • Peripheral retinal lesions like holes /tears • Patients who cannot sit for long duration • Parameters used are similar to that of slit lamp delivery system but may require higher power in dense media opacities.
  34. ENDOLASER DELIVERY • Direct laser inside the eye with an endolaser probe during parsplana vitrectomy
  35. SCATTER LASER PRP- ENDOLASER • It is 360 degree PRP given with 2 burns width occurring as distance between 2 separate burns. • Total of 800 to 1000 burns are required for complete scatter PRP. • INDICATIONS; patients undergoing pars plana vitrectomy with indicating retina lesions.
  36. FOCAL/ GRID/ BARRAGE LASERS-INDICATIONS • Clinically significant macular edema (CSME) • Pin point leaks in central serous chorioretinopathy (CSCR) • Branch retinal vein occlusions (BRVO) • Focal ablation of extrafoveal choroidal neovascular membrane • Treatment of ocular tumors • Creation of chorioretinal adhesions surrounding retinal breaks and detached areas
  37. FOCAL/GRID PHOTOCOAGULATION-LASER PARAMETERS • Spot size 50-100 microns, up to 50 to 200 microns for grid lasers. • Duration 0.1 seconds • Power 50-100 mW . Power titrated to barely whiten the microaneurysm. • Blanches RPE / microaneurysms (light to mild intensity)
  38. FOCAL LASER • Given for focal maculopathy i.e macular edema caused by focal leakage. • Laser is given directly to the microaneursyms situated between 500 to 3000 microns from fovea. • This stops leakage by direct closure of microaneursyms thereby inducing vascular thrombosis.
  39. FOCAL LASER CONTD • If vision is less than 6/9 with persistent edema and good peri foveolar network on FFA then focal laser up to 300 microns from fovea may be considered. • The spot size should be reduced to 50 microns and duration to 0.05 second in above senerio.
  40. EFFECT OF FOCAL PHC- BEFORE AND AFTER LASER • Newer RPE replaced • Causes existing RPE cells to absorb more fluid. • Stimulates endothelial proliferation which promotes better integrity of blood - retinal barrier
  41. GRID LASER • Grid pattern of laser is given for diffuse macular edema i.e macular edema caused by diffuse leakage. • The laser is applied to edematous areas avoiding foveal avascular zone (FAZ), around 500 microns from fovea. • The spacing should be one burn width apart. • It can be given in papillomacular bundle also but it should remain 500 microns from the disc.
  42. LASERS IN SPECIFIC CASES • ROP; Aim is to ablate the entire avascular retina from the ridge upto the ora serrata in a near confluent burn pattern getting as close to the ridge as possible RETINAL BREAK; Two-three rows of confluent burns ꟷ Spot size: 200-500 μm ꟷ Mild to moderate burn intensit
  43. LASERS IN CHOROIDAL NEOVASCULARIZATION (CNV) • Choroidal neovascularization (CNV) Conventional(direct) laser: 532 nm frequency doubled YAG or argon green (514 nm) • The membrane is first delimited by moderate intensity non-confluent laser spots extending to at least 100 μ of the surrounding normal retina • Subsequently, intense confluent burns are applied to the membrane until uniform whitening is observed.
  44. PHOTOCOAGULATION FOR NEOVASCULARIZATION IN SCD • Sector Laser parameters • Spot size: 200-500 μm • Pulse duration: 100 ms • Power: 200-250 mW
  45. RECENT ADVANCES -PASCAL (PATTERN SCAN LASER) PHOTOCOAGULATION • PASCAL Photocoagulator is the latest laser machine. • It is a semi-automated pattern generation technique that allows the rapid delivery of 532 nanometer laser pulses in a predetermined sequence.
  46. ADVANTAGES OF PASCAL • Very fast and more efficient than standard single shot • Improved comfort: Patients are likely to experience less discomfort and therefore have more tolerance for the procedure. • Full 360 degrees PRP can be done in a single sitting • Advanced precision: Macular Grid treatment provides an improved margin of safety and dosimetry control when compared with single shot treatments.
  47. PASCALADVANTAGES CONTD • Unlike the irregular pattern placement obtained in single shot photocoagulation, PASCAL delivers even pattern burns. • Easier to use as physician training is minimal and photocoagulation is the same with conventional lasers.
  48. RECENT ADVANCES -SELECTIVE RPE THERAPY (SRT): MICROPULSE LASER • Light is strongly absorbed by melanosomes in the RPE • Application of microsecond laser pulses allows for confinement of the thermal and mechanical effects of this absorption within the RPE layer, thus sparing the photoreceptors and the inner retina. • Sub-thresh hold • Subsequent RPE proliferation and migration restores continuity of the RPE layer • Lack visible changes in retina • CSR, DM
  49. RECENT ADVANCES; NAVIGATED LASERS • NAVILAS an example • 532-nm pattern-type eye-tracking laser integrateslive colour fundus imaging, red-free and infra-red imaging, • FFA with photocoagulator system • After image acquisition and making customized treatment plans by the ophthalmologist • Marking areas which will be coagulated, the treatment plan is superimposed onto the live digital retina image during treatment • The ophthalmologist controls laser application and the systems assist with prepositioning the laser beam
  50. COMPLICATIONS OF LASER PROCEDURES • Discomfort • Ocular Pain, headache • Anterior segment; corneal or lenticular opacification • Transient visual loss • Photocoagulation of the fovea • Macular edema • Hemorrhage: Vitreous • Choroidal Effusion • Color vision alterations • Visual field defects and night vision problems • Iatrogenic retinal break • Vitreoretinal traction
  51. CONCLUSION • Although, the advent of anti-VEGF has taken over as first line option in many previous indications of retinal laser photocoagulation. • Recent advancements and introduction of retinal sparing lasers with improved visual outcome will no doubt advance the use of Lasers in retina disease conditions. • Therefore, understanding the basics of retinal laser photocoagulation is paramount.
  52. REFERENCES • Shah PK, Prabhu VV, Morris RJ. Pan Retinal Photocoagulation (PRP), Focal Laser & Photodynamic Therapy (PDT) Technique & Tips. eOphtha. [accessed mach 21, 2023]. Available from https://www.eophtha.com/posts/pan-retinal-photocoagulation-prp-focal-laser-photodynamic-therapy- pdt-technique- tips#:~:text=Under%20topical%20anaesthesia%2C%20place%20lens,obtain%20clear%20view%20of% 20retina. • David G Telander DG, Dahl AA. Retinal Photocoagulation. Medscape. Updated: Jul 26, 2016. [accessed mach 21, 2023]. Available from https://emedicine.medscape.com/article/1844294-overview#a3 • Classification and treatment of Diabetic Retinopathy: diabetic maculopathy In: AMP Hamilton, MW Ulbig, P Polkinghorne, editors.Management of Diabetic Retinopathy. 1st Indian edition reprint 2003 Jaypee Brothers medical publishers Pvt Ltd New Delhi; 2003;
  53. REFERENCES CONTD • Chhabiani J et al Restorative retina laser therapy; present state and future direction. Surveey of ophthalmology. Scirnce Direct • Abouammoh MA et al. Lase surgey. Eye wiki available from www.eyewiki.aao.org/lasers_(surgery)# • Rosenblatt RJ, Benson WJ. Diabetic Retinopathy. In: Yanoff M, ed.Opthalmology. 2nd ed. St. Louis, MO: Mosby; 2004;877- 887. • Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report no. 3. The Early Treatment Diabetic Retinopathy Study Research Group. Int Ophthalmol Clin. 1987 Winter;27(4):254-64. • Aveline, B, Hasan, T, Redmond, RW (1994) Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA)Photochem Photobiol59,328-335 • Schmidt–Erfurth, U, Hasan, T, Gragoudas, E, Michaud, N, Flotte, TJ, Birngruber, R. (1994) Vascular targeting in photodynamic occlusion of subretinal vesselsOphthalmology101,1953-1961
  54. THANK YOU
Publicidad